CRISPR is capable of more than we initially expected

What does 14 years of gene editing actually add up to? Jennifer Doudna, the Nobel Prize-winning biochemist who co-invented CRISPR, walks through the full arc of the technology she helped create.

She covers the FDA-approved, functionally curative — but $2 million — CRISPR therapy for sickle cell disease, efforts to reduce methane emissions from cattle and rice farming, and the ongoing ethical reckoning. Doudna also reflects on how CRISPR’s early framework for responsible use compares to today’s AI race, and where she thinks gene editing goes from here.

This video is featured on Big Think.